Quality of Life Grants

Targeted Research Initiative for Youth
Application Deadline: March 2, 2009
Award Amount: up to $100,000 for one year

Apply
The Epilepsy Foundation is pleased to announce its first annual Targeted Research Initiative for Youth grant program.This program recognizes the increasing need for epilepsy and seizure research in populations from children through adolescence involving pathophysiology, epidemiology, diagnosis, behavioral manifestations, medication therapy, and quality-of-life issues.

The Foundation invites research grant applications from investigators interested in psychosocial problems and comorbidities of children and adolescents with epilepsy including, but not limited to topics such as psychiatric comorbidity; treatment of behavioral and cognitive comorbidities, including innovative techniques such as utilization of internet or computer based technologies; studies of the impact of impaired social cognition on educational and occupational outcomes; difficulties and treatment gaps for adolescents transitioning to adulthood; social supports for adolescents with epilepsy; health access and literacy including family communication with health care professionals; the impact of other health conditions (e.g. sleep difficulties, migraines, etc.) on epilepsy treatment and outcome.

Applicants may request up to $100,000 for one year. Grants awarded for higher than $50,000 per year are based on funds available and may be offered if the applicant proposes particularly meritorious work and has provided clear justification based on need and timetable of the work proposed.

Epilepsy Foundation 8301 Professional Place Landover MD 20785 (800) 332 1000

Accessible America is a $25,000 award competition open to all cities and towns across the nation. Its purpose is to recognize and promote replication of exemplary practices that communities use to facilitate the comprehensive involvement of citizens with disabilities in community life.

Michelle Colvard, the reigning Ms. Wheelchair America, will launch the National Organization on Disability’s (NOD) eighth Accessible America Award at AARP Headquarters in Washington, D.C. October 29. NOD is issuing the call for entries in celebration of National Disabilities Employment Awareness Month. American mayors and chief elected officials are invited to enter their communities in the Accessible America competition, open to all U.S. cities and towns, each year. Communities compete for a $25,000 cash prize and the distinction of being identified as one of the best places in the U.S. for people with disabilities to live, learn, work and play. AARP is the lead sponsor of the Accessible America 2009 competition.

Application must be postmarked no later than midnight, December 31, 2008 and submitted to: Accessible America Competition 2009
457 Main St #6
Lewiston, ME 04240

Email: ability@nod.org

The Hartford Geriatrics Health Outcomes Research Scholars Awards Program

Application Deadline:
December 5, 2008
Start of Grant:
July 1, 2009
Amount:
$100,000 per year for two years
Number of Awards:
Up to 4 awards will be made in 2009.

AWARD OVERVIEW

The John A. Hartford Foundation and the American Association for Geriatric Psychiatry
Foundation for Health in Aging are pleased to announce The Hartford Geriatrics Health Outcomes
Research Scholars Awards Program. This program supports physician-scientists committed to
improving the health care of older adults during the
critical transition from junior faculty to independent
researcher. The John A. Hartford Foundation wants
to invest in scholars with leadership potential and
who aspire to improve health care for older adults.
For the purposes of this grant, outcomes research
is defined as the study of functional status,
impairments, perceptions, social opportunities, and
health services utilization that are influenced by
disease, injury, treatment, or health policy, including
etiology, diagnosis, and intervention. Research must
be focused on older adults and may address clinical
strategies and effectiveness, innovative outcomes
measures, and quality of life.

Hartford Outcomes Scholars must have a research
sponsor who has a strong background in training and
outcomes research, as well as expertise and interest
in the outcomes research that is being proposed.
A Selection Committee, comprised of distinguished
academic physicians will review the applications and
select up to four candidates to receive the award.

The Hartford Geriatrics Health Outcomes Research Scholars Awards Program is a
career development program aimed at junior level physician-scientist faculty at US
academic medical (allopathic or osteopathic) institutions. To be eligible, the applicant
must:
• have a MD or DO degree;
• hold a full-time faculty appointment at the level of assistant professor in a
clinician-scientist track, for no more than two years at the time the grant becomes
effective. (For applicants who are in the process of securing a faculty position, a
letter from their future Department Chair or Division Head must accompany the
application asserting the institution’s commitment to the applicant and when the
faculty position will become effective.)
• demonstrate the motivation and ability to devote the majority (75%) of his or her
time to conduct outcomes research related to improving the care of older adults
with the goal of devoting his/her research career to this area;
• be either:
• a geriatrician or geriatric psychiatrist who has completed all of the
requirements to be eligible to sit for a Geriatric Medicine Certification Exam by
the time the award commences (July 1, 2009); or
• a general internist, family physician, neurologist, or subspecialist of internal
medicine who is pursuing a career devoted to aging research and who has
completed all the requirements to be eligible to sit for Board Certification in
his/her discipline;
• have at least two years of prior experience which includes:
• at least one year of clinical experience at an accredited US institution; and
• at least one year of research training at an US academic institution.

The applicant must:
a. Demonstrate a strong commitment to an academic career devoted to improving
the care of older adults.
b. Plan to devote 75% of professional time to research efforts.

FOR FURTHER INFORMATION
Visit www.healthinaging.org
The American Geriatrics Society
Foundation for Health in Aging
The Empire State Building
350 Fifth Avenue, Suite 801
New York, NY 10118

Mentored New Investigator Research Grant to Promote Diversity

Competition objectives

The Mentored New Investigator Research Grant to Promote Diversity (MNIGD) is a three-year award intended to be a research-based and mentoring investment in the process of closing the health disparities gap between diverse and non-diverse investigator populations. The Alzheimer’s Association feels strongly that the mentoring and involvement of diverse researchers in independently funded Alzheimer’s research is a pressing need. The MNIRGD is intended to enhance the capacity of diverse and non-diverse scientists to conduct basic, clinical and social/behavioral research.

The MNIRGD competition has the following general requirements:

* foster mentoring relationships between experienced researchers and those not previously funded or considered new investigators (under 10 years post degree);
* increase the diversity presence of scientists conducting research on Alzheimer’s and related dementias;
* enhance the research skills and scientific visibility of junior faculty from diverse backgrounds;
* support mentoring relationships that will establish enduring research careers of diverse researchers.

The purpose of this competition is to provide underrepresented new investigators with mentored funding that will allow them to develop preliminary or pilot data, to test procedures, and to develop hypotheses. The intent is to support early-career development through mentorship that will lay the groundwork for future research grant applications to the National Institutes of Health, National Science Foundation and other funding agencies and groups, including future proposals to the Alzheimer's Association. All applications submitted to the Mentored New Investigator Research Grant to Promote Diversity program must target defined areas of focus for fiscal year 2009 to be considered responsive to the program announcement.

Mentor's statement required for MNIRGD

The mentor should be experienced in conducting Alzheimer’s and related dementia research and in mentoring investigators. The application must include a statement from the selected mentor that includes information on his/her research qualifications and experience as a research supervisor. The application must also include information to describe the mentor's research support relevant to the applicant’s research plan and the nature and extent of supervision and training that he/she will provide during the period of the award. The primary mentor must agree to provide annual evaluations of the applicant’s progress for the duration of the award, as required for the yearly progress report.

Mentoring relationships may include early-career researchers and/or fostering the recruitment of mid-career scientists into Alzheimer’s and related dementia research. The applicant and proposed mentor must specify a mechanism for assuring effective mentoring. The application should contain a plan for and an evaluation strategy of the mentoring process for enhancing diversity in the professional research workforce. Specific benchmarks are outlined below and considered by the Alzheimer’s Association as critical for the development of early-career investigators. A successful mentorship plan should include some of these benchmarks but should not be limited to these alone. Mentor's statement will be limited to one page.

Required MNIRGD benchmarks:

* Attendance at an Association-sponsored luncheon for mentors and new investigators at the Association’s International Conference on Alzheimer’s Disease (ICAD)
* Acceptance of an abstract at ICAD
* Mandatory documentation of hours spent on face-to-face mentoring
* Citation of specific exercises of mentorship such as supervision of manuscript writing and submission, grant writing and submission
* Specific instances of the facilitation of networking, introductions to colleagues and/or inclusion in discussions at scientific meetings
* Submission of a proposal to an Alzheimer’s Association grant program or submission of a grant proposal to the NIH or NSF
* Submission of an application to the NIA’s Summer Institute (suggested but not required)

General requirements for MNIRGD

Funding and award period: The Alzheimer’s Association anticipates funding up to five NIRGD/MNIRGD awards total under this competition. Each MNIRGD award is limited to $170,000. A total of $150,000 will be awarded for costs related to the proposed research for up to three years (direct and indirect costs). Requests in any given year may not exceed $60,000 (direct and indirect costs). Indirect costs are capped at 10 percent (rent for laboratory/office space is expected to be covered by indirect costs paid to the institution). The Principal Investigator must commit to a 50 percent effort toward the proposed project over the three-year funding period.

The remaining funds, $10,000 to the applicant and $10,000 to the primary mentor, will be awarded upon successful completion of the three-year program. These additional funds are to be applied to sustaining ongoing research in the Alzheimer’s field and will be awarded through the applicant’s and mentor’s institutions. Successful completion of the program includes, but is not limited to, reaching all of demonstrable benchmarks listed above.

Eligibility: Eligibility for this grant competition is restricted to investigators who have less than 10 years of research experience after receipt of their terminal degree. Eligible applicants are faculty members who have been determined by the grantee institution to be underrepresented on faculty in biomedical and behavioral research on a national or institutional basis, such as individuals from racial and ethnic groups and individuals with disabilities. Nationally underrepresented groups in biomedical research careers include but are not limited to African-Americans, Hispanic Americans, American Indians/Alaska Natives, Native Hawaiians and Pacific Islanders.

Young investigators currently funded through other mentored awards (federal or other) are ineligible to apply for this award.

The 10-year period applies to the date of submission of the grant application. Adjustments for career interruptions can be made. These would include, but are not limited to, family leave, military service and major illness or injury. It is the responsibility of the applicant to point out and document such interruptions. In general, postdoctoral fellows are not eligible to apply for an MNIRGD grant. The only exception is the special case in which an applicant can provide a letter indicating they will have a full-time faculty position, such as an assistant professorship, by the application deadline. The letter of employment must be on hiring institution letterhead and must indicate that the position will be activated by the grant award date. If the anticipated position is not activated by the award date for any reason, any offer of funding will be withdrawn.

Deadlines and award dates: Letters of intent must be received by 5:00 PM EASTERN STANDARD TIME, December 1, 2008. Letters of intent will not be accepted after this date. No exceptions will be made.

Applications must be received by 5:00 p.m. EASTERN STANDARD TIME, January 8, 2009. Scientific and technical review will be conducted from February through May 2009.

The second-level review by the Medical and Scientific Advisory Council will be conducted during June 2009. Funding will be awarded by July 2009.

Mechanism of award, reporting requirements and allowable costs: The mechanism of the award is the individual research grant. The maximum allowable duration is three years. Annual progress and financial reports are required. Continuation of the grant over the awarded duration is contingent upon the timely receipt of scientific and financial reports as well as a mentor’s report outlining progress toward meeting MNIRGD benchmarks.

Allowable costs under this award:

* It is required that most of the funds awarded under this program be used for direct research support.

Allowable costs under this award include:

* Purchase and care of laboratory animals
* Small pieces of laboratory equipment and laboratory supplies
* Computer equipment if used strictly for data collection
* Travel (up to 1,000 per year)
* Salary for the principal investigator, scientific (including post-doctoral fellows) and technical staff (including laboratory technicians and administrative support related directly to the funded project)

Costs not allowed under this award include:

* Tuition
* Computer hardware or software for investigators
* Rent for laboratory/office space
* Construction or renovation costs

Budget: A “budget summary” for the proposed research project is required and must be submitted with the application and within the allowable page limits. However, if the application is to be awarded, a more detailed budget will be required and must be approved prior to the disbursement of funds. Your budget must not exceed the maximum amount of the award ($150,000 for MNIRGD).

Everyday Technologies for Alzheimer Care Grant

Everyday Technologies for Alzheimer Care (ETAC) is a cooperative research funding initiative sponsored by the Alzheimer’s Association and Intel Corporation. ETAC seeks proposals on personalized diagnostics, preventive tools and interventions for adults coping with the spectrum of cognitive aging and neurodegenerative disease, particularly Alzheimer’s disease.

We are interested in new groundbreaking studies on emerging information and communication technologies (ICTs) as well as their clinical and social implications. Strongest consideration will be given to novel innovative ideas rather than more evolutionary incremental research. Originality of the study is more important than extensive evidence for why it is a logical next step in a research program.

ETAC is designed to support exploratory multidisciplinary research that would not typically be funded by national health and science granting foundations. Minor iterations in testing plans or populations will not be considered for funding. Collaboration between social science/medical/public health and computer science/engineering researchers is valued. Mobile computing, high bandwidth sensing, robotics, imaging, face recognition, natural language processing, statistical modeling and a host of other technology advances allow unprecedented opportunities to study disease progression and therapeutic strategies in the context of everyday life.

ETAC supports research that integrates such emerging technology capabilities with leading directions in behavioral science and biomedical research. Grants that merely create Internet-based versions of existing services or paper tools will not be considered. Submissions must be original ideas, not continuations of previously funded ETAC projects. Please see links provided below for examples of studies that have been funded by ETAC.

The following list of research topics is not exhaustive; we invite researcher-initiated proposals in any of these or other topic areas.

1. Behavioral assessment for early detection: What kinds of behavioral data can be captured through everyday devices for the early detection of Alzheimer’s? Are there key speech/conversational features that today’s or tomorrow’s cell phones could help to analyze for early detection? Are there gait and other movement patterns that home camera systems could capture to provide early warnings of potential cognitive conditions? How might different forms of dementia be differentiated by the analysis of such video and audio data? How can data from sensors, imaging and traditional clinical measures be triangulated to enhance assessment?

2. Prevention: How can technologies foster the cognitive resilience and reserve that may protect against dementia? How can innovative systems provide the cognitive, social and physical engagement (throughout the lifespan) that may prevent or delay Alzheimer’s disease and related disorders? How can such systems motivate lifestyle changes and help people manage health conditions to limit vulnerability to dementia?

3. Safety monitoring and support for caregivers: How can new technologies augment and improve upon existing safety monitoring systems? What acoustic and visual cues can be relied upon to help identify and triage patients’ needs? For example, how can advances in high bandwidth sensing and statistical inferencing help detect and prevent falls?

4. Supporting independent function in daily life: Early-stage products based on wireless sensor networks have been developed to support activities of daily living―how can additional processing capabilities improve upon these systems? What analytic tools could identify changes in individuals’ typical patterns and provide customized assistance?

5. Social support through face or audio recognition: How might speech, face and voice recognition technologies provide diagnosed individuals with real-time, just-in-time feedback, reminders and support for their social interactions? Can these technologies help someone with memory loss to keep track of past conversations, topics and social encounters in a way that does not require great effort or technological expertise? How can mobile technologies (for example, phones, hearing aids, and watches) serve as social assistants?

6. Detecting moments and patterns of lucidity: Given the sometimes weekly, daily or even hourly variability of function of many people with Alzheimer’s, how can we identify the optimal times for a patient to conduct complex household tasks like bill paying or self-medication? How can technologies help to find opportune moments for interacting with someone with Alzheimer’s?

7. Privacy and security concerns of Alzheimer’s families: What privacy and security concerns do families and patients with Alzheimer’s have regarding home monitoring? How do these concerns differ according to generational, regional, cultural, gender and other differences? How can technology help people negotiate the sharing of health-related information?

ETAC applicants are strongly encouraged to consider partnerships with chapters of the Alzheimer’s Association when it is advantageous to the goals of the project.

The Alzheimer's Association recognizes the need to increase the number of scientists from underrepresented groups in the research enterprise. Researchers from these groups are encouraged to apply.

Funding and award period: The Association anticipates funding 4 awards under this program. Each total award is limited to $200,000 (direct and indirect costs) for up to three years. Requests in any given year may not exceed $90,000 (direct and indirect costs). Indirect costs are capped at 10 percent (rent for laboratory/office space is expected to be covered by indirect costs paid to the institution).

Eligibility: Researchers with full-time staff or faculty appointments are encouraged to apply. ETAC applications from post-doctoral candidates will not be accepted.

Ineligibility: The Alzheimer's Association will not accept new research grant applications from currently funded Alzheimer's disease investigators who are delinquent in submitting interim/final scientific or interim/final financial reports on active grants. This policy will be strictly adhered to with no exceptions.

Deadlines and award dates: Letters of intent (LOIs) must be received by 5:00 p.m. EASTERN STANDARD TIME, December 1, 2008. Letters of intent will not be accepted after this date. No exceptions will be made.

Applications must be received by 5:00 p.m. EASTERN STANDARD TIME, January 8, 2009. Scientific and technical review will be conducted from February through May 2009.

The second-level review by the ETAC Review Board and Medical and Scientific Advisory Council will be conducted during June 2009. Funding will be awarded by July 2009.

Mechanism of award, reporting requirements and allowable costs: The mechanism of the award is the individual research grant. The maximum allowable duration is three years. Annual progress and financial reports are required. Continuation of the grant over the awarded duration is contingent upon the timely receipt of scientific and financial reports.

Budget: A “budget summary” for the proposed research project is required and must be submitted with the application and within the allowable page limits. However, if the application is to be awarded, a more detailed budget will be required and must be approved prior to the disbursement of funds. Your budget must not exceed the maximum amount of the award ($200,000 for ETAC).

Allowable costs under this award:

It is required that most of the funds awarded under this program be used for direct research support.
Other allowable costs include:

Small pieces of laboratory equipment and laboratory supplies
Salary for the principal investigator, scientific (including postdoctoral fellows) and technical staff (including laboratory technicians and administrative support related directly to the funded project)
Purchase and care of laboratory animals
Purchase of a computer
Support for travel to scientific and professional meetings, not to exceed $1,000 per year
Costs not allowed under this award include:

Tuition
Rent for laboratory/office space
Construction or renovation costs
Multiple and overlapping submissions: If separate proposals are submitted to different grant competitions, each proposal submitted must be distinctly different. Only one proposal will be funded if scores for multiple submissions fall within funding range of different grant categories.

Applicants cannot submit two proposals in the ETAC grant competition ― even if the proposals are distinctly different.
Active ETAC or Consortium Funding Recipients: Overlapping funding of more than one Alzheimer’s Association grant is not allowed. Investigators who have an active Alzheimer's Association or Intel grant may apply for another award that is clearly new work rather than an extension of their current grant. The new research proposal can be proposed in the last year of their grant if that last year concludes by the time the new funding year begins on July 1.

Current holders of awards for support of research related to the project described in the ETAC LOI (whether these awards arise from federal or private sources, but especially if awards arise from other Alzheimer's Association or Intel program resources) are obliged to provide sufficient detail (e.g., budgetary detail, specific aims) so that it is clear that the LOI represents novel research.

An LOI for work that might be viewed as an extension of an existing line of (funded) research should clearly but briefly distinguish goals and progress for the current funding period from goals proposed in the LOI for the next period. The responsibility lies with the applicant to include rationale to dispel any notion of "double dipping" or "re-dipping.” As with most grantmaking programs, ETAC recognizes that scientific overlap may occur across funded grants; as is also usually the case, budgetary overlap is not permitted. Coincidentally awarded grants must be negotiated in good faith according to this principle. ETAC program staff are available to assist PIs at the LOI stage to avoid the possibility of administrative disqualification at the full proposal review stage.

For additional information, contact grantsapp@alz.org or call 312.335.5747 or 312.335.5889.

American Society of Transplantation Allied Health Professionals Grant

This is a two-year grant ($40,000/year) for Allied Health Professionals

This is a two-year grant ($40,000/year) awarded for studies that focus on topics related to transplant candidate and recipient outcomes and well-being, quality of life, compliance, and aspects of transplant-related drugs that affect patient care (including dosing, side effects, pharmacokinetics, and pharmacogenetics). Studies should be designed to answer specific question(s). Preference will be given to prospective studies.

Application Deadline: MIDNIGHT Eastern time ON FRIDAY, November 21, 2008

IMPORTANT REMINDERS
All applications for the AST Faculty Grants must be completed by Midnight Eastern Time on Friday, November 21, 2008. The application site for the AST Awards and Grants Program will automatically shut down after the deadline. No application or supplementary documents will be accepted after the submission deadline.
Letters of recommendation with original/electronic signatures on institutional letterhead must be uploaded electronically to the online application. Original letters of recommendation must be mailed to the AST National Office, postmarked by the submission deadline and have an original signature on institutional letterhead.
Confirmation e-mails will be sent out once an application is complete.
DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the AST Awards and Grants Program. Such proposals must be IRB-approved. Any responsibility will be assumed by the P.I. and the funded institution.

Eligibility criteria
Appointment and Institutional Resources: At the time of the application, the applicant must have a staff position at an accredited medical center or institution of higher learning and be an established member of the transplant team. The applicant’s Administrative Supervisor (or Chief of Transplantation) must write a letter stipulating that the applicant has the institutional resources for conducting independent research (office space, computer, statistical back-up; access to medical records) and the applicant’s Administrative Supervisor must specifically stipulate the amount of protected research time should this grant be awarded.

Membership
The applicant must be an active member of the AST by the submission deadline and the proposed work is to be performed in a North American Medical Center. The applicant's membership dues must be paid to date by March 1, 2009. Otherwise, the application will not be considered for funding.

Education
The applicant must hold a degree and have completed any advanced training commensurate with their position at the time of the application. Allied Health Professionals include but are not limited to: Transplant Coordinators (CCTC), staff nurses (RN), nurse practitioners (RN, NP, CRNP, FNP, ACNP); clinical nurse specialists (CNS); physician assistants (PA-C), social workers (MSW); and Doctors of Pharmacy (Pharm D). Allied health professionals must have sufficient advanced training and experience to perform the proposed work.

Citizenship
The applicant must be either: a) US, Canadian, or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the US, Canada, or Mexico with a valid visa during the award period, or c) a foreign national admitted lawfully for residence in the US, Canada, or Mexico during the awarded period. Funding will not be released until visa status is confirmed.

Previous funding
An individual cannot apply for an AST Allied Health Professionals Grant if he/she has been awarded this grant in the past or if the applicant serves as the PI on a previous or current R01, project on a P01 grant, VA Merit award or comparable non-mentored award.

American Society of Transplantation
15000 Commerce Parkway
Suite C
Mt.Laurel, NJ,08054

Phone: 856.439.9986
Fax: 856.439.9982

Email: ast@ahint.com

American Society of Pediatric Otolaryngology Daiichi Innovative Technology Grant

Open to MD, PhD, DMD, DO researchers to fund exploratory or hypothesis-generating projects that apply innovative technology for education or research in pediatric otolaryngology. Full patent and copyright control must be retained by the applicant and the applicant’s institution, but applicant may be required to return funds to the Society if patented innovations generate more than $5,000. One year, non-renewable, $5,000, one available. NOTE: It is recommended that the Research Plan for this grant only be 3-pages (max of 10) and the department chair and support letters are optional.

The Daiichi Innovative Technology Grant will fund exploratory or hypothesis-generating projects that are
not well-suited to a formal grant application (eg, based on statistical analysis and sample size
specification) such as:
1. development of new surgical or diagnostic instruments
2. survey or quality of life measures
3. new use of internet technology or computer software such as CDs or DVDs
4. educational brochures, materials, software for patients or physicians
5. other applications of innovative technology for education or research in pediatric otolaryngology
Full patent and copyright control must be retained by the applicant and the applicant’s institution. If
patented innovations funded by this award generate more than $5,000, the applicant may be required to
return funds to the Society.
ELIGIBILITY
Researchers (MD, PhD, DMD, DO) in disciplines who will conduct research directly relevant to innovative
technology in pediatric otolaryngology are eligible to apply. Applications submitted by otolaryngologists or
demonstrating collaborations with otolaryngologists are preferred. Participation of an ASPO member is
not required, but is preferred. ASPO will consider applications from both:
(1) Individuals:
a. Unaffiliated with an institution may submit a grant application from the individual
himself/herself. In the event of a grant award, an ASPO check would be drawn to the
individual investigator. This could be considered as income to that individual and
therefore subject to income tax.
b. Affiliated with institutions (i.e., universities) may apply individually if allowed by university
policy. In the event of a grant award, an ASPO check would be drawn to the individual
investigator (See Signatures and Approvals).
(2) Institutions: organization exempt from income taxation pursuant to Section 501(c)(3) of the
Internal Revenue Code (other than a private foundation). Submission of a W9 form documenting
501(c)(3) status to the ASPO Treasurer will be required (US institutions only) prior to release of
funds. Investigators affiliated with institutions (i.e., universities) who are not allowed by university
policy to apply individually, may ask the university to submit the grant application for the
investigator’s project. Investigators in this category are considered institutional applicants. In the
event of a grant award, an ASPO check would be drawn to the Institution (see Signatures and
Approvals).
CONDITIONS
If the principal investigator is a trainee (resident or student), the grant application must be accompanied
by letters of support from the principal scientific advisor or mentor indicating a general level of support of
the applicant, the fact that the Department will make time, space, and other resources accessible for
completion of the project, and that the applicant will have appropriate supervision/support throughout the
period of the grant.
TERMS
1. Amount: $5,000 total costs; no more than 10% indirect costs allowed.
2. Period: 12 months, non-renewable. One-year no-cost extensions may be requested from the Chair of
the ASPO Research Committee (see www.aspo.us for contact information). Any funds remaining two
years after the initial award must be returned to ASPO.

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Academy of Otolaryngology - Head and Neck Surgery Rande H. Lazar Health Services Research Grant

Open to any Otolaryngologist at any level in the U.S. or Canada. Project must focus on ENT socioeconomic health services research. One year, non-renewable, $10,000 maximum total cost, one available annually.

The purpose of the Rande H. Lazar Health Services Research Grant is to support the gathering of
socioeconomic data for otolaryngology. The award is intended to promote increased participation by otolaryngologists in the rapidly expanding area of health services research.

ELIGIBILITY
Any otolaryngologist in the United States or Canada is eligible to apply for the Rande H. Lazar Health
Services Research Grant. Applicants may be independent practitioners, residents or fellows in an
approved training program, or practitioners affiliated with academic or similar institutions. All applicants
must be members in good standing of AAO-HNSF; Associate and Corresponding Members are not
eligible to apply as Principal Investigator, but may participate actively in the proposed project. Past
recipients of AAO-HNS Foundation grants are eligible to apply, as are individuals who have competed
successfully for independent research grant support from a private or Federal funding agency. Special
consideration will be given to projects with a socioeconomic focus, however projects that look to develop
and disseminate scientific information on the effects of otolaryngology services and procedures on
patients' survival, health status, functional capacity, and quality of life will also be accepted for
consideration.
CONDITIONS
Proposed projects may be related to any area of otolaryngology-head and neck surgery, but must have
direct or potential clinical significance for patients seen by otolaryngologist-head and neck surgeons.
They must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative and promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources. Basic science projects or projects
using animal models are not appropriate for this grant program.
Applications must be accompanied by a letter of support from the applicant’s Department Chair verifying
that the applicant will be permitted to devote an appropriate amount of time to the conduct and timely
completion of the proposed research project. Applicants must also obtain letters of
support/understanding from all key personnel on the project.
TERMS
1. Amount: $10,000 maximum total (direct and indirect) costs
2. Period: One year, non-renewable.
3. Funding: The Foundation's Board of Directors will determine the total number of awards authorized
each year, since available funding is contingent on the earnings of the Foundation's Research and
Development Fund. Actual award of the grant(s) will depend on the merit of the applications
received.
4. Use of Funds: Award funds may be used for any legitimate costs associated with the purpose of the
Award, other than salary support for the Principal Investigator. A detailed budget and budget
justification constitute part of the application and will be evaluated as an important factor in the review
process. If university policy stipulates that a portion of this very modest award must go toward
institutional indirect costs, no more than ten percent (10%) of the total costs may be applied for
indirect costs.

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

IADR/GlaxoSmithKline Innovation in Oral Care Awards
Supported by GlaxoSmithKline

Deadline: December 1, 2008

INTRODUCTION:
The Innovation in Oral Care Awards (“Award(s)”) are jointly sponsored by IADR and GlaxoSmithKline (GSK), with funding provided exclusively by GSK.
The IADR mission is to advance research and increase knowledge for the improvement of oral health worldwide. It does so through its Divisions and Sections as well as in partnership with international dental associations, industry, health agencies, and scientific and educational professional organizations. These innovation awards offer opportunities for investigators to conduct dental research that will have a direct impact on the oral health of the public.

As a leader in consumer oral care, GSK recognizes the need for pioneers to produce innovative technologies that can be used routinely by the public to maintain and improve oral health and quality of life. The Award(s) is intended to help investigators pursue innovative and novel research in oral care, above and beyond the bounds of traditional dental research.

Competitive Award(s), of up to $75,000 each, will be provided to recipients to advance oral care programs directed toward the development of innovative and novel compounds, biomaterials or devices that can be used ultimately at the public health level. Examples of areas of interest could include, but not be limited to:

inhibition or removal of biofilms etc. adhering to natural or artificial surfaces,
modification of those surfaces to inhibit biofilms and other deposits, stains and odors,
adhesives for removable prosthetic devices,
inhibition of tooth surface loss and gingival recession, and amelioration of their effects, and
counteracting the oral effects of dry mouth, systemic illness, hormonal disturbances or physiological aging.
The Award(s) will be provided in the form of an unrestricted research grant which carries no obligation to the recipient’s organization for licensure, patenting, or transfer confidential information, although GSK may discuss the possibility of future collaboration with some applicants.

CRITERIA FOR PROPOSALS:

1) For the purposes of this Award Program, oral care is defined as:

a) products, devices or delivery systems used frequently by consumers to maintain or improve their oral health status and quality of life, and /or
b) devices fabricated by the assistance of dental professionals and placed in the oral cavity, and which require frequent or daily maintenance by the consumer.

2) Any proposed innovation or new technology should provide significant benefits to the consumer, such as improved oral health and/or quality of life.

3) Ultimately the proposed innovations or technologies should be available to large numbers of people through retail channels such as ‘over-the-counter’ (OTC) or general sale. Initially, however, it may be appropriate for availability to be on a prescription basis for a limited period before transitioning to OTC.

4) Restorative materials, dental instruments and equipment, and diagnostics for non-oral conditions should not receive much consideration unless the technological advance provides significant benefit to the oral health and quality of life status of the public.

ELIGIBILITY:

The principal investigator listed in the application must be a current member of, or at the time of submission have made bona fide application to, IADR. To fulfill the quest for innovation, proposals should be collaboratively sponsored by at least one researcher whose principal expertise is in an area of biotechnology other than a dental science. The intent is to encourage collaboration with researchers from outside the dental institution; nevertheless, the most important criterion involves the innovative nature of the proposed research. In any case, applicants should possess advanced degrees and must hold an affiliation with an academic center, not-for-profit institution, or for-profit entities such as biotechnology start-up companies. Letters of support from the principal investigator’s (PI) institution are required and should describe the nature of the PI’s appointment and commitments to the PI, such as lab and office space, technical assistance or travel funds.

APPLICATIONS and FURTHER INFORMATION:

Except for disclosures to IADR or GSK as agreed to by applicant, all applicants shall agree not to disclose their application or the contents thereof to others until June 30, 2009. After the judging process has been completed, GSK will have access to applicant names, their institutions, the proposal title and abstract only, and may wish to discuss potential commercialization of the concepts disclosed in the applications with the applicants, if the applicants so agree.

Completed applications should be submitted online (www.dentalresearch.org) before the closing date of December 1, 2008. Further information can be obtained from the Sheri S. Herren, Awards, Fellowships & Grants Manager (Email: sherren@iadr.org). Interested parties are welcome to submit a brief proposal letter outlining the research to IADR and asking for a determination as to whether such research would qualify for consideration.